Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential.

Tigyi GJ, Johnson LR, Lee SC, Norman DD, Szabo E, Balogh A, Thompson K, Boler A, McCool WS

Open source

DOI: 10.1194/jlr.s091744
Published: 2019 Mar
Container: Journal of lipid research
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1194/jlr.s091744,
  title = {Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential.},
  author = {Tigyi GJ and Johnson LR and Lee SC and Norman DD and Szabo E and Balogh A and Thompson K and Boler A and McCool WS},
  year = {2019},
  journal = {Journal of lipid research},
  doi = {10.1194/jlr.s091744},
  url = {https://doi.org/10.1194/jlr.s091744}
}

RIS

TY  - JOUR
TI  - Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential.
AU  - Tigyi GJ
AU  - Johnson LR
AU  - Lee SC
AU  - Norman DD
AU  - Szabo E
AU  - Balogh A
AU  - Thompson K
AU  - Boler A
AU  - McCool WS
PY  - 2019
JO  - Journal of lipid research
DO  - 10.1194/jlr.s091744
UR  - https://doi.org/10.1194/jlr.s091744
ER  -

APA

GJ, T., LR, J., SC, L., DD, N., E, S., A, B., K, T., A, B., & WS, M. (2019). Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential.. Journal of lipid research. https://doi.org/10.1194/jlr.s091744

Source records

pubmed · retrieved 2026-09-26T17:40:32.750Z
europe-pmc · retrieved 2026-09-26T17:40:32.762Z
doaj · retrieved 2026-09-26T17:40:32.765Z